Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences has filed for an initial public offering in the US, seeking to raise up to $200 million.

The Menlo Park, Calif.-based maker of a single-molecule, real-time sequencing (SMRT) technology platform, today filed a preliminary prospectus with the US Securities and Exchange Commission for the offering. It has not said how many shares that it intends to offer or when it anticipates the IPO will become effective

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.

Dec
17
Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.